- Filed
- Mar 3, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Jan 31, 2025 | 5.76M sh |
| Cash And Equivalents | Q2 2025 · Jan 31, 2025 | $681 |
| Cash And Equivalents | Q2 2025 · Jul 31, 2024 | $1.85K |
| Current Liabilities | Q2 2025 · Jan 31, 2025 | $10.67K |
| Current Liabilities | Q2 2025 · Jul 31, 2024 | $13.19K |
| Total Liabilities | Q2 2025 · Jan 31, 2025 | $10.67K |
| Total Liabilities | Q2 2025 · Jul 31, 2024 | $13.19K |
| Current Assets | Q2 2025 · Jan 31, 2025 | $11.19K |
| Current Assets | Q2 2025 · Jul 31, 2024 | $12.76K |
| Total Assets | Q2 2025 · Jul 31, 2024 | $12.89K |
| Total Assets | Q2 2025 · Jan 31, 2024 | $4.89K |
| Shares Diluted | Q2 2025 · Jan 31, 2024 | 5.04M sh |
| Shares Diluted | Q2 2025 · Jan 31, 2024 | 5.04M sh |
| Operating Cash Flow restated | Q2 2025 · Jan 31, 2024 | $491 |
| Stockholders Equity | Q2 2025 · Jan 31, 2024 | −$6.33K |
| Stockholders Equity | Q2 2025 · Oct 31, 2023 | −$6.21K |
| Stockholders Equity | Q2 2025 · Jul 31, 2023 | $5.79K |
| Eps Diluted | Q2 2025 · Jan 31, 2024 | $0.00 |
| Eps Diluted | Q2 2025 · Jan 31, 2024 | $0.00 |
| Eps Basic | Q2 2025 · Jan 31, 2024 | $0.00 |
| Eps Basic | Q2 2025 · Jan 31, 2024 | $0.00 |
| Net Income | Q2 2025 · Jan 31, 2024 | −$120 |
| Net Income | Q2 2025 · Jan 31, 2024 | −$12.11K |
| Net Income | Q2 2025 · Oct 31, 2023 | −$11.99K |
| Operating Income | Q2 2025 · Jan 31, 2024 | −$120 |
| Operating Income | Q2 2025 · Jan 31, 2024 | −$12.11K |
| Revenue | Q2 2025 · Jan 31, 2024 | $10K |
| Revenue | Q2 2025 · Jan 31, 2024 | $15K |